Innovation of clinical trials in China: Commentary on the publication of “CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration”

Taixiang Wu; Zhaoxiang Bian; Hongcai Shang; Youping Li

doi:10.1111/jebm.12268

Innovation of clinical trials in China: Commentary on the publication of “CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration”

Taixiang Wu, Zhaoxiang Bian, Hongcai Shang, Youping Li^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	155-162
Number of pages	8
Journal	Journal of Evidence-Based Medicine
Volume	10
Issue number	3
DOIs	https://doi.org/10.1111/jebm.12268
Publication status	Published - Aug 2017

Scopus Subject Areas

Health Policy

User-Defined Keywords

checklist
Chinese herbal medicine formulas
clinical trial
CONSORT
data sharing
reporting guideline

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jebm.12268

Cite this

@article{04ae0114affb48b09fb5c91275e93ce6,

title = "Innovation of clinical trials in China: Commentary on the publication of “CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration”",

keywords = "checklist, Chinese herbal medicine formulas, clinical trial, CONSORT, data sharing, reporting guideline",

author = "Taixiang Wu and Zhaoxiang Bian and Hongcai Shang and Youping Li",

year = "2017",

month = aug,

doi = "10.1111/jebm.12268",

language = "English",

volume = "10",

pages = "155--162",

journal = "Journal of Evidence-Based Medicine",

issn = "1756-5383",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

Innovation of clinical trials in China: Commentary on the publication of “CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration”. / Wu, Taixiang; Bian, Zhaoxiang; Shang, Hongcai et al.
In: Journal of Evidence-Based Medicine, Vol. 10, No. 3, 08.2017, p. 155-162.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Innovation of clinical trials in China

T2 - Commentary on the publication of “CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration”

AU - Wu, Taixiang

AU - Bian, Zhaoxiang

AU - Shang, Hongcai

AU - Li, Youping

PY - 2017/8

Y1 - 2017/8

KW - checklist

KW - Chinese herbal medicine formulas

KW - clinical trial

KW - CONSORT

KW - data sharing

KW - reporting guideline

UR - http://www.scopus.com/inward/record.url?scp=85028570370&partnerID=8YFLogxK

U2 - 10.1111/jebm.12268

DO - 10.1111/jebm.12268

M3 - Review article

C2 - 28857507

AN - SCOPUS:85028570370

SN - 1756-5383

VL - 10

SP - 155

EP - 162

JO - Journal of Evidence-Based Medicine

JF - Journal of Evidence-Based Medicine

IS - 3

ER -

Innovation of clinical trials in China: Commentary on the publication of “CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration”

Scopus Subject Areas

User-Defined Keywords

UN SDGs

Access to Document

Other files and links

Cite this